Advanced search
Publication Cover
mAbs Volume 15, 2023 - Issue 1
Submit an article Journal homepage
5,186
Views
4
CrossRef citations to date
0
Altmetric
Report

Efficient production of bispecific antibody by FAST-IgTM and its application to NXT007 for the treatment of hemophilia A

Hikaru Kogaa Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9693-5334View further author information
ORCID Icon,
Takashi Yamanoa Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanORCID Iconhttps://orcid.org/0000-0001-5998-4532View further author information
ORCID Icon,
Juan Betancurb API Process Development Department, Chugai Pharmaceutical Co., Ltd, Ukima, Tokyo, JapanView further author information
,
Satoko Nagatomoc Analytical Development Department, Chugai Pharmaceutical Co, Ltd, Ukima, Tokyo, JapanView further author information
,
Yousuke Ikedac Analytical Development Department, Chugai Pharmaceutical Co, Ltd, Ukima, Tokyo, JapanView further author information
,
Kazuki Yamaguchia Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanView further author information
,
Yoshiaki Nabuchia Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanView further author information
,
Kazuki Satoa Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanView further author information
,
Yuri Teranishi-Ikawaa Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanORCID Iconhttps://orcid.org/0000-0003-1558-2608View further author information
ORCID Icon,
Motohiko Satoa Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanView further author information
,
Hiroyuki Hirayamaa Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanView further author information
,
Akira Hayasakaa Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanView further author information
,
Takuya Torizawaa Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanORCID Iconhttps://orcid.org/0000-0001-7537-6123View further author information
ORCID Icon,
Kenta Harayaa Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanORCID Iconhttps://orcid.org/0000-0002-9142-5607View further author information
ORCID Icon,
Zenjiro Sampeia Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanORCID Iconhttps://orcid.org/0000-0001-5343-4468View further author information
ORCID Icon,
Hirotake Shiraiwaa Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanView further author information
,
Takehisa Kitazawaa Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanView further author information
,
Tomoyuki Igawad Translational Research Division, Chugai Pharmaceutical Co., Ltd, Chuo-Ku, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0003-0097-8220View further author information
ORCID Icon &
Taichi Kuramochia Research Division, Chugai Pharmaceutical Co., Ltd, Yokohama, Kanagawa, JapanORCID Iconhttps://orcid.org/0000-0001-7242-7124View further author information
ORCID Icon show all
Article: 2222441 | Received 16 Mar 2023, Accepted 02 Jun 2023, Published online: 20 Jun 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.